P02766 (TTHY_HUMAN) Homo sapiens (Human)

Transthyretin UniProtKBInterProSTRINGInteractive Modelling

147 aa; Sequence (Fasta)
Identical sequences: Homo sapiens: E9KL36

Available Structures

333 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
The structure of human retinol binding protein with its carrier protein transthyretin reveals inter… Heteromer
P02753;
RTL;21-147
Assess
Complex of TTR and RBP4 and Oleic Acid Heteromer
P02753;
11×SO4;OLA;21-144
Assess
RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN Heteromer
P02753;
REA;25-147
Assess
Crystal structure of the transthyretin-retinol binding protein-Fab complex Heteromer
P02753;
RTL;27-145
Assess
Atomic-resolution structure of a cross-beta protofilamenthomo-16-mer125-135
Assess
transthyritin derived amyloid fibril from patient with hereditary V30M ATTR amyloidosishomo-11-mer31-143
Assess
THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30ME…homo-4-mer21-147
Assess
THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30ME…homo-4-mer21-147
Assess
TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBR…homo-4-mer21-147
Assess
THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30ME…homo-4-mer21-147
Assess
TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBR…homo-4-mer21-147
Assess
TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBR…homo-4-mer21-147
Assess
TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBR…homo-4-mer21-147
Assess
TRANSTHYRETIN (DEL VAL122)homo-4-mer21-147
Assess
TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBR…homo-4-mer21-147
Assess
STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROM…homo-4-merMIL;25-147
Assess
TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINEhomo-4-merP28;27-147
Assess
TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)homo-4-merSO4;T44;30-147
Assess
MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3,3'-DIIODO-L-THYRONINE BINDING TO HUMAN …homo-4-merT33;30-147
Assess
Human transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4a…homo-4-merT4A;28-145
Assess
CRYSTAL STRUCTURE DETERMINATION AT 2.3A OF HUMAN TRANSTHYRETIN-3',5'-DIBROMO-2',4,4',6-TETRA-HYDROX…homo-4-merFL9;29-146
Assess
High Resolution Structure of Wild Type Human Transthyretin in Complex with 3,3',5,5'-tetrachloro-[1…homo-4-merPCQ;30-146
Assess
Human transthyretin (TTR) complexed with 16-alpha-bromo-estradiolhomo-4-merESZ;EDO;29-145
Assess
Human transthyretin (TTR) complexed with ferulic acid and curcumin.homo-4-merCUR;NA;EDO;FER;29-145
Assess
Human transthyretin (TTR) complexed with curcuminhomo-4-merCUR;NA;EDO;29-145
Assess
Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)ethanoic acidhomo-4-merES8;EDO;29-145
Assess
Dual binding mode for 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid binding to Human transthyretin…homo-4-mer7BD;EDO;29-145
Assess
Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effectshomo-4-mer29-145
Assess
Crystal Structure of V30M transthyretin complexed with (-)-epigallocatechin gallate (EGCG)homo-4-merKDH;GOL;29-145
Assess
Neutron structure of human transthyretin (TTR) at room temperature to 2.3A resolution (monochromati…homo-4-mer29-145
Assess
Neutron structure of human transthyretin (TTR) at room temperature to 2.0A resolution (Laue)homo-4-mer29-145
Assess
Human transthyretin (TTR) complexed with 4-hydroxy-chalconehomo-4-merIPJ;31-147
Assess
CRYSTAL STRUCTURE of HUMAN TRANSTHYRETIN IN COMPLEX WITH LUTEOLIN AT 1.1 A RESOLUTIONhomo-4-merLU2;GOL;NA;30-145
Assess
Transthyretin in complex with the fluorescent folding sensor (E)-7-hydroxy-3-(4-hydroxy-3,5-dimethy…homo-4-mer1W3;30-145
Assess
Structure of human transthyretin in complex with Tolcaponehomo-4-merTCW;30-145
Assess
V30G Transthyretin structure in complex with Tolcalponehomo-4-merTCW;30-145
Assess
Transthyretin in complex with (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzoic acidhomo-4-mer1WZ;30-145
Assess
The Structure of V122I Mutant Transthyretin in Complex with AG10homo-4-mer16V;30-145
Assess
Crystal Structure of human transthyretin (TTR) processed with the CrystalDirect automated mounting …homo-4-mer30-145
Assess
Crystal Structure of Human Transthyretin in Complex with Perfluorooctanoic acid (PFOA)homo-4-mer8PF;NA;30-145
Assess
Structure of human transthyretin mutant A109Vhomo-4-mer30-145
Assess
The Structure of V122I Mutant Transthyretin in Complex with Tafamidishomo-4-mer3MI;30-145
Assess
Crystal structure of transthyretin in complex with 3-deoxytolcapone, a tolcapone analoguehomo-4-merLVB;30-145
Assess
X-ray structure of perdeuterated TTR mutant - T119M at 1.22Ahomo-4-mer30-145
Assess
Kinetic Stabilization of transthyretin through covalent modification of K15 by 4-bromo-3-(5-(3,5-di…homo-4-mer0UC;30-145
Assess
Kinetic stabilization of transthyretin through covalent modification of K15 by (E)-N-(4-(4-hydroxy-…homo-4-mer18J;30-145
Assess
X-ray structure of TTR mutant - T119M at 1.22A resolutionhomo-4-mer30-145
Assess
X-ray structure of TTR mutant - S52P at 1.23A resolutionhomo-4-merGOL;30-145
Assess
High resolution crystal structure of human transthyretin bound to ligand and conjugates of 3-(5-(3,…homo-4-mer4AJ;30-145
Assess
Crystal structure of human transthyretin in complex with luteolin-Cl at 1.25 A resolutionhomo-4-mer7LU;NA;GOL;30-145
Assess
Transthyretin in complex with (3,4-dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanonehomo-4-mer3M1;30-145
Assess
Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid in a dual b…homo-4-mer6BD;GOL;30-145
Assess
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and thei…homo-4-merSO4;R3X;DMS;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with Perfluoroktansulfonsyra (PFOS)homo-4-merP8S;NA;30-145
Assess
Crystal structure of human transthyretin in complex with 3-O-methyltolcapone, a tolcapone analoguehomo-4-merLVE;30-145
Assess
Wild Type Human Transthyretin pH 7.5homo-4-merCA;30-145
Assess
X-ray structure of perdeuterated TTR mutant - S52P at 1.28A resolutionhomo-4-merGOL;30-145
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTIONhomo-4-mer30-145
Assess
Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analoguehomo-4-merJTE;30-145
Assess
X-ray structure of wild-type TTR at 1.30A resolutionhomo-4-mer30-145
Assess
Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analoguehomo-4-merJTN;30-145
Assess
Structure of human transthyretin mutant A108Vhomo-4-mer30-145
Assess
Human transthyretin (TTR) complexed with (2,7-Dichloro-fluoren-9-ylideneaminooxy)-acetic acid.homo-4-mer5JW;30-145
Assess
Transthyretin in complex with a covalent small molecule kinetic stabilizerhomo-4-merA93;30-145
Assess
High resolution crystal structure of human transthyretin bound to ligand and conjugates of 4-(5-(3,…homo-4-mer2WN;4B8;30-145
Assess
Crystal structure of human transthyretin in complex with luteolin-MeO at 1.35 A resolutionhomo-4-mer6B5;NA;30-145
Assess
Transthyretin in complex with (E)-N-(3-(4-hydroxy-3,5-dimethylstyryl)phenyl)acrylamidehomo-4-mer16L;30-145
Assess
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and thei…homo-4-merSO4;R4G;30-145
Assess
Crystal structure of human transthyretin mutant T119M at pH 5.5homo-4-mer30-145
Assess
Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6homo-4-mer15×ZN; 12×ACT;GOL;30-145
Assess
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and thei…homo-4-merSO4;R3S;DMS;30-145
Assess
Crystal structure of Transthyretin-quercetin complexhomo-4-merDMS;QUE;30-145
Assess
Structure of transthyretin in complex with the kinetic stabilizer 201homo-4-merIIH;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with Tetrabromobisphenol A (TBBPA)homo-4-merXDI;NA;30-145
Assess
Crystal structure of V30M mutated transthyretin in complex with alpha-mangostinhomo-4-merMKS;CL;CA;30-145
Assess
Crystal Structure Of Human Transthyretin in complex with 2,4,5-trichlorophenoxyacetic acid (2,4,5-T)homo-4-merF52;30-145
Assess
Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloro-4…homo-4-mer0UA;30-145
Assess
Human transthyretin (TTR) complexed with (2,7-Dibromo-fluoren-9-ylideneaminooxy)-acetic acidhomo-4-merL32;DMS;30-145
Assess
Crystal structure of DACM wild type Transthyretinhomo-4-mer30-145
Assess
X-ray structure of perdeuterated wild-type TTR at 1.42A resolutionhomo-4-mer30-145
Assess
Crystal Structure of Human Transthyretin Ser85Pro Mutanthomo-4-merNA;CL;30-145
Assess
Crystal structure of human transthyretin double mutant K35T/T119Mhomo-4-mer30-145
Assess
Wild-type Transthyretin in complex with 3-[(1E)-2-(4-Hydroxyphenyl)ethenyl]benzoic Acidhomo-4-merXOS;30-145
Assess
Structure of human transthyretin mutant A108Ihomo-4-mer30-145
Assess
Crystal structure of transthyretin in complex with CHF4795, a flurbiprofen analoguehomo-4-merJTK;30-145
Assess
Wild-type Transthyretin in complex with 3-[(1E)-2-(2-Chloro-4-boronic acid)ethenyl]benzoic Acidhomo-4-merXLB;30-145
Assess
Kinetic stabilization of transthyretin through covalent modification of K15 by (E)-N-(4-(4-hydroxy-…homo-4-mer18A;30-145
Assess
Human transthyretin (TTR) complexed with 4-(3-(2-flourophenoxy)propyl)-3,5-dimethyl-1H-pyrazolehomo-4-mer3M3;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with Clonixinhomo-4-mer6J3;NA;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with 2,2',4,4'-tetrahydroxybenzophenone (BP2)homo-4-mer27M;NA;GOL;30-145
Assess
Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen analoguehomo-4-merH50;PO4;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with 2,6-Dinitro-p-cresol (DNPC)homo-4-mer6J1;NA;30-145
Assess
Crystal structure of V30M mutated transthyretin in complex with gamma-mangostinhomo-4-merMKT;CL;30-145
Assess
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and thei…homo-4-merD75;30-145
Assess
Wild-type Transthyretin in complex with 1,1'-(1E)-(1,2-Ethenediyl)bis[2-chloro-4-boronic acid]benze…homo-4-merIWW;30-145
Assess
Wild-type Transthyretin in complex with 5-[(1E)-2-(4-Boronic acid)ethenyl]-1,3-benzenediolhomo-4-merS4B;30-145
Assess
Human transthyretin (TTR) complexed with 5-(2-ethoxyphenyl)-3-(pyridin-4-yl)-1,2,4-oxadiazolehomo-4-mer3M4;30-145
Assess
Covalent modification of transthyretin K15 by yielding the fluorescent conjugate (E)-3-(dimethylami…homo-4-mer1W4;30-145
Assess
Human transthyretin (TTR) complexed with (Z)-((3,4-Dichloro-phenyl)-methyleneaminooxy)-acetic acidhomo-4-merL57;30-145
Assess
Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxystilbenehomo-4-merLJ2;30-145
Assess
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and thei…homo-4-merG7G;30-145
Assess
Human Transthyretin Ser52Pro Mutanthomo-4-merCA;30-145
Assess
Crystal structure of TTR/resveratrol/T4 complexhomo-4-merT44;STL;30-145
Assess
Crystal structure of V30M mutant human transthyretin complexed with nordihydroguaiaretic acidhomo-4-mer30Z;30-145
Assess
Wild-type Transthyretin in complex with 3-[(1E)-2-(2-Chloro-4-hydroxyphenyl)ethenyl]benzoic Acidhomo-4-merXLO;30-145
Assess
Wild type human transthyretin (TTR) complexed with GC-1 (TTRwt:GC-1)homo-4-merB72;GOL;30-145
Assess
Crystal structure of human transthyretin double mutant R34G/T119M at pH 5.5homo-4-mer30-145
Assess
Human transthyretin (TTR) complexed with (R)-3-(9H-fluoren-9-ylideneaminooxy)-2-methyl-N-(methylsul…homo-4-mer48R;GOL;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with 3,5,6-Trichloro-2-pyridinyloxyacetic acid …homo-4-merSBK;NA;30-145
Assess
Crystal structure of transthyretin variant V20Shomo-4-mer30-145
Assess
Crystal structure of V30M mutant human transthyretin complexed with dihydroguaiaretic acidhomo-4-merPWK;30-145
Assess
Crystal Structure of the Wild Type TTR Binding Naringenin (TTRwt:NAR)homo-4-mer20×EDO;NAR;CA;30-145
Assess
Crystal structure of the apo form of human wild-type transthyretinhomo-4-mer30-145
Assess
Crystal structure of the transthyretin mutant A108Y/L110E solved in space group p21212homo-4-mer30-145
Assess
Structure of human transthyretin mutant E89Khomo-4-mer30-145
Assess
Crystal Structure Of Human Transthyretin in complex with 3,5,6-trichloro-2-pyridinol (TC2P)homo-4-merF4Z;NA;30-145
Assess
Crystal Structure of Human Transthyretin Lys15Trp Mutanthomo-4-mer29-144
Assess
A25T Transthyretin structure in complex with Tolcalponehomo-4-merTCW;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with 4,4'-Dihydroxydiphenyl sulfone (Bisphenol …homo-4-mer6JD;NA;30-145
Assess
Crystal structure of human transthyretin variant A25T - #1homo-4-merPGE;30-145
Assess
Crystal structure of transthyretin in complex with CHF5074 at neutral pHhomo-4-merH50;30-145
Assess
transthyretin with tethered inhibitor on one monomer.homo-4-merP2C;30-145
Assess
Crystal structure of TTR variant I84S in complex with CHF5074 at acidic pHhomo-4-merH50;30-145
Assess
Crystal structure of transthyretin in complex with diflunisal at acidic pHhomo-4-mer1FL;30-145
Assess
Human TTR altered by a rhenium tris-carbonyl Pyta-C8 derivativehomo-4-merDMS;EDO;ACT;RE;IMD;30-145
Assess
Wild-type Transthyretin in complex with 3-[(1E)-2-(4-Boronic acid)ethenyl]benzoic Acidhomo-4-merXBS;30-145
Assess
Crystal structure of the transthyretin mutant TTR C10A/Y114Chomo-4-mer12×BME;30-145
Assess
Crystal structure of human transthyretin variant V30M in complex with luteolinhomo-4-merLU2;NA;30-145
Assess
Crystal structure of Human Transthyretin (E54G)homo-4-merGOL;SO4;30-145
Assess
Crystallographic study of novel transthyretin ligands exhibiting negative-cooperativity between two…homo-4-mer30-145
Assess
The crystal structure of 2,4-dinitrophenol in complex with human transthyretinhomo-4-merSO4;DNF;30-145
Assess
Crystal structure of DACM F87M/L110M Transthyretin mutanthomo-4-merCL;ACT;30-145
Assess
V30M mutant human transthyretin (TTR) complexed with GC-24 (V30M:GC-24)homo-4-merGOL;G24;30-145
Assess
Crystal structure of transthyretin in complex with iododiflunisalhomo-4-merFHI;30-145
Assess
Structure of human transthyretin complex with analgesic inhibitorhomo-4-merFQ7;NA;30-145
Assess
Y114C Transthyretin structure in complex with Tolcalponehomo-4-merTCW;30-145
Assess
Human transthyretin (TTR) complexed with (E)-3-(((4-hydroxybenzylidene)amino)oxy)propanoic acidhomo-4-merNEK;29-144
Assess
Crystal structure of the F87M/L110M mutant of human transthyretin at pH 6.5homo-4-mer12×ZN;GOL;ACT;30-145
Assess
Crystal Structure of Human Transthyretin in Complex with Gemfibrozilhomo-4-mer4TX;NA;30-145
Assess
Crystal Structure of Human Transthyretin Val30Met Mutanthomo-4-mer30-145
Assess
Crystal Structure of the Wild Type TTR Binding Chrysin (TTRwt:CHR)homo-4-mer57D;30-145
Assess
V30M mutant human transthyretin (TTR) complexed with GC-1 (V30M:GC-1)homo-4-merB72;GOL;30-145
Assess
Crystal structure of the F87M/L110M mutant of human transthyretin at pH 5.5homo-4-mer12×ZN; 10×ACT;GOL;30-145
Assess
Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6 soakedhomo-4-mer12×ZN;ACT;GOL;30-145
Assess
Crystal structure of V30M mutant human transthyretin complexed with caffeic acid ethyl esterhomo-4-mer0XR;CA;30-145
Assess
Crystal structure of V30M mutant human transthyretin complexed with caffeic acid 1,1-dimethylallyl …homo-4-merPWH;CA;30-145
Assess
Wild-type Transthyretin in complex with 2-Boronic Acid-1-[(1E)-2-(3-boronic acid)ethenyl]-4-chlorob…homo-4-mer7UV;30-145
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-18homo-4-merHKA;30-145
Assess
Crystal structure of transthyretin variant L58H at acidic pHhomo-4-mer30-145
Assess
Structure of human transthyretin complexed with bromophenols: a new mode of bindinghomo-4-merGOL;PBR;30-145
Assess
Crystal structure of human transthyretin variant A25T - #2homo-4-merPGE;30-145
Assess
Structure of human transthyretin complexed with bromophenols: a new mode of bindinghomo-4-merTBP;30-145
Assess
Human TTR crystals soaked in manganese chloride.homo-4-merMN;30-145
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-17homo-4-merFT0;30-145
Assess
Crystal structure of transthyretin mutant I84S at PH 7.5homo-4-mer30-145
Assess
Human TTR altered by a rhenium tris-carbonyl Pyta-C12 derivativehomo-4-merEDO;PEG;RE;ACT;DMS;IMD;30-145
Assess
Crystal structure of transthyretin variant L55P at neutral pHhomo-4-mer30-145
Assess
Human transthyretin (TTR) complexed with (S)-3-(9H-fluoren-9-ylideneaminooxy)-2-methylpropanoic aci…homo-4-mer6BD;29-144
Assess
Crystal structure of human transthyretin at pH 4.6homo-4-mer30-145
Assess
X-ray structure of human transthyretin (TTR) at room temperature to 1.9A resolutionhomo-4-mer30-145
Assess
Crystal structure of transthyretin variant L55P at acidic pHhomo-4-mer30-145
Assess
Crystal structure of human transthyretin in complex with 1-amino-5-naphthalene sulfonatehomo-4-mer5NS;30-145
Assess
Crystal structure of V30M mutated transthyretin in complex with 3-isomangostinhomo-4-merMKU;30-145
Assess
Crystal Structure of the Wild Type TTR Binding Luteolin (TTRwt:LUT)homo-4-merLU2;30-145
Assess
Crystal structure of wild-type human transthyretin in complex with sulindachomo-4-merSUZ;30-145
Assess
Structure of human transthyretin complexed with bromophenols: a new mode of bindinghomo-4-mer30-145
Assess
Crystal structure of wild-type human transthyretin in complex with sulindachomo-4-merSUZ;30-145
Assess
Crystal structure of wild-type human transthyretinhomo-4-mer30-145
Assess
Crystal Structure of the Wild Type TTR Binding Apigenin (TTRwt:API)homo-4-merAGI;GOL;30-145
Assess
Wild-type Transthyretin in complex with 5-[(1E)-2-(2-Chloro-4-boronic acid)ethenyl]-1,3-benzenediolhomo-4-mer7VG;30-145
Assess
Crystal structure of human transthyretin - wild typehomo-4-mer30-145
Assess
Crystal structure of human transthyretin with bound chloridehomo-4-mer12×CL;30-145
Assess
Crystal structure of the F87M/L110M mutant of human transthyretin at pH 7.5homo-4-mer12×ZN;ACT;GOL;30-145
Assess
Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4)homo-4-merT44;30-145
Assess
Crystal structure of transthyretin mutant 87-110-117homo-4-mer30-145
Assess
V30M mutant human transthyretin (TTR) complexed with genistein (V30M:GEN) pH 7.5homo-4-merGEN;30-145
Assess
Crystal Structure of Human Transthyretin (E54K)homo-4-mer10×GOL;SO4;30-145
Assess
Wild type human transthyretin (TTR) complexed with GC-24 (TTRwt:GC-24)homo-4-merG24;30-145
Assess
CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT CRYO TEMPERATUREhomo-4-mer12×BME;30-145
Assess
Structure of transthyretin L55P in complex with Znhomo-4-merZN;CAC;30-145
Assess
Crystal structure of human transthyretin in complex with lumiracoxibhomo-4-merLUR;30-145
Assess
Crystal structure of wild-type human transthyretin in complex with indomethacinhomo-4-merIMN;30-145
Assess
Crystal structure of Human Transthyretin (wild-type)homo-4-merSO4;GOL;30-145
Assess
Transthyretin natural mutant A25Thomo-4-mer30-145
Assess
Crystal Structure of the Wild Type TTR Binding Kaempferol (TTRwt:KAE)homo-4-merKMP;30-145
Assess
Crystal structure of human wild-type transthyretin in complex with diclofenachomo-4-merDIF;30-145
Assess
Crystal structure of wild-type human transthyretin in complex with lumiracoxibhomo-4-merLUR;30-145
Assess
Crystal structure of wild-type human transthyretin in complex with sulindachomo-4-merSUZ;30-145
Assess
Crystal structure of human transthyretin in complex with indomethacinhomo-4-merIMN;30-145
Assess
Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2homo-4-mer30-145
Assess
Crystal structure of transthyretin mutant I84A at neutral pHhomo-4-mer30-145
Assess
Wild-type Transthyretin in complex with 5-[(1E)-2-(2-Chloro-4-hydroxyphenyl)ethenyl]-1,3-benzenediolhomo-4-merS2L;30-145
Assess
Crystal structure of the highly amyloidogenic transthyretin mutant TTR G53S/E54D/L55S- heated prote…homo-4-mer30-145
Assess
Crystal structure of transthyretin variant V30M at acidic pHhomo-4-mer30-145
Assess
Crystal structure of transthyretin variant Y114Hhomo-4-mer30-145
Assess
CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55Shomo-4-mer30-145
Assess
Crystal structure of transthyretin variant Y114H at acidic pHhomo-4-mer30-145
Assess
Crystal structure of transthyretin variant T60A at acidic pHhomo-4-merACT;30-145
Assess
Human TTR altered conformation from soaking in CuCl2.homo-4-merCU;PEG;ACT;EDO;30-145
Assess
Human TTR altered conformation from soaking in iron chloride.homo-4-merACT;FFE; 10×FE;30-145
Assess
LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTUREhomo-4-mer30-145
Assess
MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4)homo-4-merT44;30-145
Assess
Neutron structure of human transthyretin (TTR) S52P mutant at room temperature to 1.8A resolution (…homo-4-mer30-145
Assess
Neutron structure of human transthyretin (TTR) T119M mutant at room temperature to 1.85A resolutionhomo-4-mer30-145
Assess
Neutron structure of human transthyretin (TTR) S52P mutant in complex with tafamidis at room temper…homo-4-mer3MI;30-145
Assess
Human Transthyretin (TTR) complexed with 2-((3,5-dichloro-4-hydroxyphenyl)amino)benzoic acidhomo-4-merCJZ;30-144
Assess
Transthyretin in complex with 5-(4-nitrophenylazo)-3-iodosalicylic acidhomo-4-merBQB;30-144
Assess
Human transthyretin (TTR) complexed with 2-(3,5-Dimethyl-4-hydroxyphenyl)benzoxazolehomo-4-merMR4;31-145
Assess
Structure of wild-type TTR in complex with tafamidishomo-4-mer3MI;31-145
Assess
Crystal structure of E61K mutated transthyretinhomo-4-merCA;30-144
Assess
Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-2,5-dichlorobenzamidehomo-4-merDZ2;31-145
Assess
Transthyretin in complex with (E)-2,6-dibromo-4-(2,6-dimethoxystyryl)anilinehomo-4-merIW6;31-145
Assess
Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-3,5-dimethyl-4-hydroxybenz…homo-4-merDZ3;31-145
Assess
Crystal structure of transthyretin in complex with apigeninhomo-4-merAGI;30-144
Assess
Crystal Structure of Human Transthyretin Glu92Pro Mutanthomo-4-merPO4;GOL;NA;30-144
Assess
Human transthyretin (TTR) complexed with N-(3,5-Dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamidehomo-4-merDZ1;31-145
Assess
Crystal structure of Transthyretin complexed with pterostilbenehomo-4-merSO4;DMS;3RL;30-144
Assess
Human transthyretin (TTR) in Apo-formhomo-4-mer31-145
Assess
Human Transthyretin (TTR) complexed with a palindromic bivalent amyloid inhibitor (7 carbon linker).homo-4-merJZE;30-144
Assess
Crystal structure of transthyretin in complex with L6homo-4-merL6Y;30-144
Assess
Transthyretin in complex with 2,6-dibromo-4-(2,6-dichlorophenethyl)phenolhomo-4-merIW2;31-145
Assess
Transthyretin in complex with (E)-4-(4-aminostyryl)-2,6-dibromophenolhomo-4-merIW3;31-145
Assess
Transthyretin in complex with (E)-4-(3-aminostyryl)-2,6-dibromoanilinehomo-4-merIW4;31-145
Assess
Crystal structure of V30M mutant human transthyretinhomo-4-mer30-144
Assess
Human transthyretin (TTR) in complex with N-(3,5-Dibromo-4-hydroxyphenyl)benzamidehomo-4-merLJ5;31-145
Assess
Crystal Structure of Human Transthyretin Ser85Pro/Glu92Pro Mutanthomo-4-merNA;GOL;PEG;30-144
Assess
Crystal structure of Cys10 sulfonated transthyretinhomo-4-merSO4;30-144
Assess
Structure of Human Transthyretin Val30Met Mutant in Complex with Tafamidishomo-4-mer3MI;30-144
Assess
Human transthyretin (TTR) complexed with 2-(3,5-Dimethylphenyl)benzoxazolehomo-4-merMR6;31-145
Assess
Human transthyretin (TTR) complexed with (E)-3-(((3,5-dibromo-2-hydroxybenzylidene)amino)oxy)propan…homo-4-merND5;GOL;PGO;30-144
Assess
Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (4 carbon linker)homo-4-mer44C;30-144
Assess
Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloroph…homo-4-mer0U7;31-145
Assess
Transthyretin in complex with (E)-4-(4-aminostyryl)-2,6-dibromoanilinehomo-4-merIW5;31-145
Assess
Crystal structure of V30M mutated transthyretin with bromide in complex with alpha-mangostinhomo-4-merMKS; 12×BR;30-144
Assess
Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acidhomo-4-merROA;30-144
Assess
Structure of Human Transthyretin Asp38Ala Mutant in Complex with Diflunisalhomo-4-mer1FL;30-144
Assess
Crystal structure of V30M mutated transthyretin with bromide in complex with gamma-mangostinhomo-4-merMKT; 16×BR;30-144
Assess
Human transthyretin (TTR) complexed with 2-(3,5-Dibromo-4-hydroxyphenyl)benzoxazolehomo-4-merMR5;31-145
Assess
Structure of Human Transthyretin Asp38Ala Mutanthomo-4-merACT;30-144
Assess
Structure of Human Transthyretin Val30Met/Thr119Met Mutanthomo-4-merPEG;30-144
Assess
Crystal structure of V30M mutated transthyretin in complex with 4'-caroboxybenzo-18-Crown-6homo-4-merAJU;30-144
Assess
Human transthyretin (TTR) in complex with 3,5-Dimethyl-4-hydroxystilbenehomo-4-merLJ1;31-145
Assess
Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxybiphenylhomo-4-merLJ3;31-145
Assess
Human transthyretin (TTR) complexed with diflunisal analogues- TTR.3',5'-difluorobiphenyl-4-carboxy…homo-4-merFBC;30-144
Assess
Crystal structure of human transthyretin in complex with Benzbromaronehomo-4-merR75;30-144
Assess
Crystal Structure of Human Transthyretin Thr119Tyr Mutanthomo-4-merGOL;30-144
Assess
The X-ray crystallographic structure of the amyloidogenic variant TTR Tyr78Phehomo-4-mer30-144
Assess
Crystal structure of transthyretin in complex with 3,5-diiodosalicylic acidhomo-4-merDIU;30-144
Assess
Crystal structure of H88A mutated human transthyretinhomo-4-merMPD;MG;31-145
Assess
Crystal structure of Transthyretin mutant I84S at acidic pHhomo-4-mer30-144
Assess
Structure of Human Transthyretin Asp38Ala Mutant in Complex with Tafamidishomo-4-mer3MI;30-144
Assess
Crystal structure of human transthyretinhomo-4-merCA;30-144
Assess
Structure of Human Transthyretin Asp38Ala/Thr119Met Mutanthomo-4-merGOL;SO4;ACT;30-144
Assess
Human transthyretin (TTR) complexed with diflunisal analogues- TTR. 2',6'-Difluorobiphenyl-4-carbox…homo-4-mer26C;30-144
Assess
Crystal Structure of Human Transthyretin Thr119Met Mutanthomo-4-mer30-144
Assess
Human transthyretin (TTR) complexed with (Z)-5-(3,5-dibromo-4-hydroxybenzylidene)-imino-1-methylimi…homo-4-mer3M2;31-145
Assess
Crystal structure of V30M mutant human transthyretin complexed with ferulic acid phenethyl esterhomo-4-merPWF;30-144
Assess
Structure of Human Transthyretin Leu55Pro Mutant in Complex with Tafamidishomo-4-mer3MI;30-144
Assess
Crystal structure of V30M mutated transthyretin in complex with 18-Crown-6homo-4-merO4B;30-144
Assess
Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (6 carbon linker)homo-4-mer6CA;30-144
Assess
Human transthyretin (TTR) complexed with Diflunisal analogues- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BI…homo-4-mer3CA;30-144
Assess
Crystal Structure of Transthyretin in Complex With Ligand C-6homo-4-mer42M;30-144
Assess
Crystal Structure of Human Transthyretin Thr119Trp Mutanthomo-4-mer30-144
Assess
Transthyretin in complex with (E)-2,6-dibromo-4-(2,6-dichlorostyryl)phenolhomo-4-merIW1;31-145
Assess
Crystal structure of human transthyretinhomo-4-merMG;30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-1homo-4-mer4V2;30-144
Assess
Crystal structure of human Transthyretin (TTR) at pH 4.0homo-4-mer30-144
Assess
TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIShomo-4-mer30-144
Assess
Structure of Wild Type Human Transthyretin in Complex with Tafamidishomo-4-mer3MI;30-144
Assess
Crystal Structure of Human Transthyretin Ala108Trp Mutanthomo-4-merCL;30-144
Assess
The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin …homo-4-merDNF;30-144
Assess
Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid (inhibitor …homo-4-mer7BD;30-144
Assess
Crystal structure of V30M mutant human transthyretin complexed with glabridinhomo-4-merGBJ;30-144
Assess
Structure of Human Transthyretin Val30Met Mutant in Complex with Diflunisalhomo-4-mer1FL;ACT;30-144
Assess
The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrolhomo-4-merSO4;DES;GOL;30-144
Assess
Crystal Structure of Human Transthyretin Leu55Pro Mutanthomo-4-mer30-144
Assess
Crystal structure of human Transthyretin with bound iodidehomo-4-mer12×IOD;30-144
Assess
Crystal structure of V30M mutant human transthyretin complexed with caffeic acid phenethyl esterhomo-4-merQAP;30-144
Assess
Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4,4'-dihydroxy-3,3',…homo-4-merPCQ;30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-3homo-4-merFT2;30-144
Assess
Human transthyretin (TTR) in complex with 1,3-Dibromo-2-hydroxy-5-phenoxybenzenehomo-4-merLJ4;31-145
Assess
Crystal structure of transthyretin in complex with iododiflunisal-betaAlaOHhomo-4-merIFB;30-144
Assess
Human transthyretin (TTR) complexed with (E)-3-(2-methoxybenzylideneaminooxy)propanoic acid (inhibi…homo-4-mer8BD;30-144
Assess
V30M mutant human transthyretin (TTR) (apoV30M) pH 7.5homo-4-mer30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-7homo-4-mer43F;30-144
Assess
Wild type human transthyretin (TTR) complexed with genistein (TTRwt:GEN) pH 7.5homo-4-merGEN;30-144
Assess
Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-2',3,3',4'…homo-4-merNE1;30-144
Assess
Crystal structure of transthyretin in complex with iododiflunisal-betaAlaOMehomo-4-merIFA;30-144
Assess
Human transthyretin (ttr) complexed with diflunisalhomo-4-mer1FL;30-144
Assess
The monoclinic crystal structure of transthyretin in complex with diethylstilbestrolhomo-4-merACT;DMS;GOL;DES;30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-2homo-4-merFT1;30-144
Assess
Crystal structure of human transthyretin in complex with 1-anilino-8-naphthalene sulfonatehomo-4-mer2AN;30-144
Assess
Crystal structure of Transthyretin mutant I84A at low pHhomo-4-mer30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFENhomo-4-merFLP;30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACIDhomo-4-merOFL;30-144
Assess
Human Transthyretin (TTR) complexed with a palindromic bivalent amyloid inhibitor (11 carbon linker…homo-4-merJZD;30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACIDhomo-4-merDBF;30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICA…homo-4-merBPD;30-144
Assess
Structure of Wild Type Human Transthyretin in Complex with Diflunisalhomo-4-mer1FL;CA;30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAChomo-4-merDIF;30-144
Assess
The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin …homo-4-merDNF;30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROLhomo-4-merSTL;30-144
Assess
CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT ROOM TEMPERATUREhomo-4-mer12×BME;30-144
Assess
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETINhomo-4-mer30-144
Assess
Crystal structure of human transthyretin complexed with glabridinhomo-4-merGBJ;CA;30-144
Assess
CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L58H at neutral pHhomo-4-mer30-144
Assess
An Engineered Transthyretin Monomer that is Non-amyloidogenic - Unless Partially Denaturedhomo-4-mer30-144
Assess
Crystal structure of H88S mutated human transthyretinhomo-4-mer31-144
Assess
Crystal structure of human Transthyretin (TTR) at pH3.5homo-4-mer31-144
Assess
X-ray crystal structure of human Transthyretin at room temperaturehomo-4-mer32-145
Assess
Crystal structure of P113A mutated human transthyretinhomo-4-merSO4;CL;31-144
Assess
Crystal structure of H88Y mutated human transthyretinhomo-4-merSO4;CL;31-144
Assess
TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIShomo-4-mer30-143
Assess
Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-3,3',5,4'-…homo-4-merNE2;30-143
Assess
V122I Transthyretin structure in complex with Tolcalponehomo-4-merTCW;30-143
Assess
Crystal structure of H88F mutated human transthyretinhomo-4-merSO4;31-144
Assess
HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO]…homo-4-merFLF;30-143
Assess
Neutron crystal structure of human Transthyretinhomo-4-mer32-145
Assess
a covalent dimer of transthyretin that affects the amyloid pathwayhomo-4-mer31-143
Assess
THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-…homo-2-merT44;21-147
Assess
TRANSTHYRETIN COMPLEX WITH RETINOIC ACIDhomo-2-mer9CR;21-147
Assess
THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-…homo-2-merT44;29-146
Assess
TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANThomo-2-mer28-145
Assess
Transthyretin natural mutant A19Dhomo-2-merCA;30-145
Assess
Transthyretin in complex with (E)-5,5'-(ethene-1,2-diyl)bis(1,1-dihydroxy-3-oxo-1,3-dihydrobenzo[c]…homo-2-merS2B;30-145
Assess
Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.homo-2-merFLF;30-145
Assess
TRANSTHYRETIN THR119MET PROTEIN STABILISATIONhomo-2-merT44;30-144
Assess
Human transthyretin (TTR) complexed with Benzoxazolehomo-2-mer205;30-144
Assess
Human Transthyretin (TTR) complexed with(E)-3-(2-(trifluoromethyl)benzylideneaminooxy)propanoic aci…homo-2-mer1BD;30-144
Assess
STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFI…homo-2-mer30-143
Assess
HUMAN TRANSTHYRETIN (PREALBUMIN)homo-2-mer30-143
Assess
Solution structure of the F87M/L110M variant of transthyretin in the monomeric statemonomer21-147
Assess
Solution structure of the T119M variant of transthyretin in its monomeric statemonomer21-147
Assess

Alignments